Cargando…
Acinetobacter Baumannii Phages: Past, Present and Future
Acinetobacter baumannii (A. baumannii) is one of the most common clinical pathogens and a typical multi-drug resistant (MDR) bacterium. With the increase of drug-resistant A. baumannii infections, it is urgent to find some new treatment strategies, such as phage therapy. In this paper, we described...
Autores principales: | Tu, Qihang, Pu, Mingfang, Li, Yahao, Wang, Yuer, Li, Maochen, Song, Lihua, Li, Mengzhe, An, Xiaoping, Fan, Huahao, Tong, Yigang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10057898/ https://www.ncbi.nlm.nih.gov/pubmed/36992382 http://dx.doi.org/10.3390/v15030673 |
Ejemplares similares
-
Efficacy in Galleria mellonella Larvae and Application Potential Assessment of a New Bacteriophage BUCT700 Extensively Lyse Stenotrophomonas maltophilia
por: Li, Yahao, et al.
Publicado: (2023) -
Genomic Analysis of the Serratia marcescens Bacteriophage BUCT660
por: Li, Yahao, et al.
Publicado: (2022) -
Characterization of the Bacteriophage BUCT603 and Therapeutic Potential Evaluation Against Drug-Resistant Stenotrophomonas maltophilia in a Mouse Model
por: Han, Pengjun, et al.
Publicado: (2022) -
Unveil the Secret of the Bacteria and Phage Arms Race
por: Wang, Yuer, et al.
Publicado: (2023) -
Characterization and Comparative Genomics Analysis of a New Bacteriophage BUCT610 against Klebsiella pneumoniae and Efficacy Assessment in Galleria mellonella Larvae
por: Pu, Mingfang, et al.
Publicado: (2022)